Stopping GLP-1 Medication: Weight Regain and Tapering

Stopping Wegovy follows the same pattern as any GLP-1, because Wegovy is semaglutide. Over the weeks after your last dose, the appetite effect fades and hunger drifts back toward where it was.

Without a maintenance plan, much of the lost weight tends to return over the next year, which is what extension studies of semaglutide found.

Zepbound and compounded semaglutide behave the same way: the effect belongs to the drug class, not the brand. The tapering, rebound-hunger and maintenance advice below applies to whichever GLP-1 you take.

• Appetite climbs back to pre-treatment levels, often quickly.
• The hormonal environment that drove weight gain returns.
• Metabolic rate has dropped during weight loss (adaptive thermogenesis), so you now burn fewer calories than someone of the same weight who was never heavier.

• High protein intake
• Regular strength training
• Consistent daily movement
• Enough sleep
• Stress management

Many patients may need ongoing treatment. Major medical organizations, including the American Association of Clinical Endocrinology, now recognize obesity as a chronic disease that may need long-term care, much like high blood pressure or diabetes.

Stopping blood pressure medication lets blood pressure rise again; stopping weight loss medication lets weight return.

For many people, the most effective approach is continuing at a maintenance dose, which can be lower than the dose used for weight loss. Our medication cost guide covers long-term costs.

• If cost is the issue: look at compounded options or a lower maintenance dose.
• If you reached your goal: ask your provider about a maintenance plan instead of simply stopping.